Prolonged global demand weakness
Extended downcycle in global crop protection market due to low commodity prices and geopolitical uncertainties could delay recovery.
PI / Q3-FY26 / risks
Keep the risk register visible.
PI Industries · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
high
Slow conversion of pharma and biologicals investments
Pharma and biologicals businesses are incurring quarterly losses of ₹75-80 crore, and breakeven may take longer than expected.
Working capital pressure
Trade working capital days increased sharply to 139 days, reflecting market conditions and partner support needs.
Regulatory hurdles in domestic biologicals
Regulatory issues in Indian biologicals market have impacted portfolio, though management expects resolution by Q4.